A
Amina Barhdadi
Researcher at Université de Montréal
Publications - 10
Citations - 524
Amina Barhdadi is an academic researcher from Université de Montréal. The author has contributed to research in topics: Heart failure & Heart rate. The author has an hindex of 3, co-authored 10 publications receiving 432 citations. Previous affiliations of Amina Barhdadi include University of British Columbia & Montreal Heart Institute.
Papers
More filters
Journal ArticleDOI
Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
Henk Visscher,Colin J. D. Ross,S. Rod Rassekh,Amina Barhdadi,Marie-Pierre Dubé,Hesham Al-Saloos,George S. Sandor,Huib N. Caron,Elvira C. van Dalen,Leontien C. M. Kremer,Helena J H van der Pal,Andrew M.K. Brown,Paul Rogers,Michael S. Phillips,Michael J. Rieder,Bruce Carleton,Michael R. Hayden +16 more
TL;DR: Combining multiple variants into a single-prediction model together with clinical risk factors and classification of patients into three risk groups identified multiple genetic variants in SLC28A3 and other genes associated with ACT.
Journal ArticleDOI
Pharmacogenomic determinants of the cardiovascular effects of dalcetrapib.
Jean-Claude Tardif,Eric Rhéaume,Louis-Philippe Lemieux Perreault,Jean Grégoire,Yassamin Feroz Zada,Géraldine Asselin,Sylvie Provost,Amina Barhdadi,David Rhainds,Philippe L. L’Allier,Reda Ibrahim,Ruchi Upmanyu,Eric J. Niesor,Renée Benghozi,Gabriela Suchankova,Fouzia Laghrissi-Thode,Marie-Claude Guertin,Anders G. Olsson,Ian Mongrain,Gregory G. Schwartz,Marie-Pierre Dubé +20 more
TL;DR: The effects of dalcetrapib on atherosclerotic outcomes are determined by correlated polymorphisms in the ADCY9 gene.
Journal ArticleDOI
CYP2D6 polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta-analysis
Maxime Meloche,Maxime Meloche,Michael Khazaka,Imad Kassem,Amina Barhdadi,Marie-Pierre Dubé,Marie-Pierre Dubé,Simon de Denus,Simon de Denus +8 more
TL;DR: Patients without any CYP2D6 metabolic capacities appear to have increased reduction in DBP, HR, and SBP during metoprolol treatment and may be at a higher risk of bradycardia compared to patients with active CYP 2D6 phenotypes.
Journal ArticleDOI
Genetics of symptom remission in outpatients with COVID-19.
Marie-Pierre Dubé,Audrey Lemaçon,Amina Barhdadi,Louis Philippe Lemieux Perreault,Essaïd Oussaïd,Géraldine Asselin,Sylvie Provost,Maxine Sun,Johanna Sandoval,Marc-André Legault,Ian Mongrain,Anick Dubois,Diane Valois,Emma Dedelis,Jennifer Lousky,Julie Choi,Elisabeth Goulet,Christiane Savard,Lea Mei Chicoine,Mariève Cossette,Malorie Chabot-Blanchet,Marie Claude Guertin,Simon de Denus,Nadia Bouabdallaoui,R. Marchand,Zohar Bassevitch,Anna Nozza,Daniel Gaudet,Philippe L. L’Allier,Julie Hussin,Guy Boivin,David Busseuil,Jean-Claude Tardif +32 more
TL;DR: This article conducted a genome-wide association study of time to remission of COVID-19 symptoms in 1723 outpatients with at least one risk factor for disease severity from the COLCORONA clinical trial and found a significant association at 5p13.3 (rs1173773; P = 4.94 × 10-8) near the natriuretic peptide receptor 3 gene.
Journal ArticleDOI
Genetic meta-analysis of cancer diagnosis following statin use identifies new associations and implicates human leukocyte antigen (HLA) in women.
Maxine Sun,Maxine Sun,Audrey Lemaçon,Audrey Lemaçon,Marc-André Legault,Marc-André Legault,Géraldine Asselin,Géraldine Asselin,Sylvie Provost,Sylvie Provost,Hugues Aschard,Amina Barhdadi,Amina Barhdadi,Yassamin Feroz Zada,Diane Valois,Diane Valois,Ian Mongrain,Ian Mongrain,Jean-Claude Tardif,Jean-Claude Tardif,Marie-Pierre Dubé,Marie-Pierre Dubé +21 more
TL;DR: In this paper, a GWAS meta-analysis using Cox modeling for the prediction of incident cancer was conducted in the pooled cohort and sex-stratified patients who previously participated in two phase IV trials (TNT and IDEAL) with genetic data.